Resources
Did you mean
Bristol-Myers Squibb Co. (555 results)
BNET Industries
- Bristol-Myers Squibb Co.
- Bristol-Myers Squibb is a biopharmaceutical and related health care products company. Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of...
- Bristol-Myers Squibb Co. company page on BNET »
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pfizer (PFE), Bristol Myers Squibb (BMY)
- Julie catches up with participants of the big pharma-sponsored New York AIDS Walk.
- Videos 2008-05-21
Additional Resources
- Informex to Hold Global Sourcing Strategies Conference for the Pharmaceutical Industry
- PRINCETON, N.J., Oct. 7 /PRNewswire/ -- Informex today announced that it will hold a Global Sourcing Summit for the Pharmaceutical Industry, November 10-11, at Princeton, New Jersey, USA. The two-day conference will address the next generation of operational and business strategies in the field of global pharmaceutical procurement. David...
- Articles 2008-10-07
- Eli Lilly to pay $6.5 billion to buy ImClone
- Drugmaker Eli Lilly agreed Monday to pay $6.5 billion for biotech-drug maker ImClone Systems, beating an offer by Bristol-Myers Squibb and boosting its stable of cancer drugs. The all-cash deal, which has been approved by both companies' boards, values ImClone at $70 a share. That's a...
- Articles 2008-10-07
- Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
- NEW JERSEY, Oct. 6 /PRNewswire/ -- The organizers of Informex are delighted to announce their inaugural conference on Global Sourcing for the Pharmaceutical Industry, taking place November 10th-11th 2008 at the Princeton Marriott in New Jersey USA. The conference is chaired by David Kinnear, President & CEO...
- Articles 2008-10-06
- Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., ImClone Systems Inc., LSI Corp, Infineon Technologies A.G. and ConocoPhillips
- CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Bristol-Myers Squibb Co. (NYSE: BMY), ImClone Systems Inc. (Nasdaq: IMCL), LSI...
- Articles 2008-10-06
- US cancer specialist at centre of 6.5-bln-dlr takeover battle
- WASHINGTON AFP — US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb BMS. Eli Lilly and ImClone said in a joint statement they had agreed a takeover pitched...
- Articles 2008-10-06
- Bristol-Myers Squibb Comments on Eli Lilly as New Erbitux Marketing Partner
- Will Receive $1 Billion Upon Completion of Transaction PRINCETON, N.J. -- Eli Lilly and Company (NYSE: LLY) announced today that it will acquire ImClone Systems (NASDAQ:IMCL) for $70 per share, or approximately $6.5 billion. Bristol-Myers Squibb currently owns approximately 16.6 percent of all outstanding shares of ImClone. Based...
- Articles 2008-10-06
- ImClone Announces Merger Agreement with Eli Lilly at $70 Per Share
- NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) announced today that it has entered into a merger agreement with Eli Lilly and Company (NYSE: LLY), pursuant to which Lilly has agreed to commence a tender offer for no less than a majority of the issued and outstanding shares of ImClone...
- Articles 2008-10-06
- Fitch Places Eli Lilly's 'AA' IDR on Watch Negative on ImClone Merger
- NEW YORK -- Fitch Ratings has placed Eli Lilly and Co.'s Eli Lilly Issuer Default Rating IDR and outstanding debt ratings on Rating Watch Negative as follows: -- IDR 'AA'; -- Bank loan 'AA'; -- Senior unsecured debt 'AA'; -- Short-term IDR...
- Articles 2008-10-06
- Zacks Bull and Bear of the Day Highlights: Bristol-Myers Squibb, Internap Network Services, LSI Corporation, ArvinMeritor and PS Business Parks
- CHICAGO -- Zacks Equity Research highlights Bristol-Myers Squibb (NYSE: BMY) as the Bull of the Day and Internap Network Services (Nasdaq: INAP) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on LSI Corporation (NYSE: LSI), ArvinMeritor, Inc. (NYSE: ARM) and PS Business Parks (NYSE: PSB)....
- Articles 2008-10-03
- Bristol-Myers Squibb Appoints Christopher Perley as Devens General Manager
- DEVENS, Mass. -- Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Perley has been named vice president and general manager of its Devens biologics manufacturing facility. In this role, Perley will be responsible for continuing the supervision of the project to build the Devens facility and will have overall management...
- Articles 2008-10-02
- BellwetherReport.com Analyst Opinions on HIG, BMY, ALU and BMR
- BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...
- Articles 2008-10-01
- U.S. Food & Drug Administration Approved the use of REYATAZ® Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration FDA approved the use of REYATAZ([R]) atazanavir sulfate 300 mg once-daily boosted with ritonavir 100 mg as part of combination therapy in previously untreated (treatment-naive) HIV-1 infected patients. REYATAZ boosted with ritonavir (REYATAZ/r)...
- Articles 2008-10-01
- New York Biotechnology Association and New York Academy of Sciences Launch Joint Membership Alliance for Emerging Biotech Companies
- NEW YORK -- The New York Biotechnology Association NYBA and the New York Academy of Sciences NYAS today announced an alliance designed to give emerging biotech companies reduced price access to NYAS corporate membership. The new 'Growth Partners' program will let emerging biotechnology companies who are NYBA members...
- Articles 2008-09-29
- Hagens Berman Sobol Shapiro: Judge Approves Two National Classes in AWP Drug Litigation
- AstraZeneca and Bristol-Myers Squibb face separate trials for alleged unfair and deceptive practices relating to cancer fighting drugs. BOSTON, Sept. 29 /PRNewswire/ -- Two major pharmaceutical companies are facing the fire this week after U.S. District Judge Patti Saris approved two national classes in the Average Wholesale...
- Articles 2008-09-29
- WPCS Awarded $10 Million in New Projects
- EXTON, Pa., Sept. 29 /PRNewswire-FirstCall/ -- WPCS International Incorporated , a leader in design-build engineering services for specialty communication systems and wireless infrastructure, has announced that, through its subsidiaries, it has received approximately $10 million in new projects. The contracts include projects to be completed for Bristol-Myers...
- Articles 2008-09-29
- Icahn Responds to Cornelius
- NEW YORK, Sept. 23 /PRNewswire/ -- ImClone Systems Incorporated , announced today that the following letter was sent by Carl Icahn, its Chairman of the Board, to James Cornelius of Bristol-Myers Squibb Company : September 23, 2008 Mr. James M. Cornelius Chairman and Chief Executive...
- Articles 2008-09-23
- Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share
- NEW YORK -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it is increasing its initial offer for ImClone Systems Incorporated (NASDAQ: IMCL) and intends to commence a tender offer for the currently outstanding shares of common stock of ImClone that are not already owned by Bristol-Myers Squibb for $62.00...
- Articles 2008-09-22
- Seven Summits Research Releases Comments on CAT, KO, GM, BMY, and PALM
- CHICAGO, Sept. 19 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0919Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven...
- Articles 2008-09-19
- ERBITUX® Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
- ERBITUX Is the Only Approved EGFR-Targeted Monoclonal Antibody Cancer Therapy Available for Use in Japan NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that ERBITUX([R]) cetuximab has been commercially launched in Japan...
- Articles 2008-09-19
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
- Hardware problem. Software problem. With AT&T Tech Support 360, at least it's not your problem.
-
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
- Reduce computer downtime. Click to learn more.
